154 related articles for article (PubMed ID: 33033460)
1. Role of carbohydrate antigen 19-9, carcinoembryonic antigen, and carbohydrate antigen 125 as the predictors of resectability and survival in the patients of Carcinoma Gall Bladder.
Agrawal S; Gupta A; Gupta S; Goyal B; Siddeek RAT; Rajput D; Chauhan U; Kishore S; Gupta M; Kant R
J Carcinog; 2020; 19():4. PubMed ID: 33033460
[TBL] [Abstract][Full Text] [Related]
2. Raised CA19-9 and CEA have prognostic relevance in gallbladder carcinoma.
Sachan A; Saluja SS; Nekarakanti PK; Nimisha ; Mahajan B; Nag HH; Mishra PK
BMC Cancer; 2020 Aug; 20(1):826. PubMed ID: 32867709
[TBL] [Abstract][Full Text] [Related]
3. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Role of Preoperative Serum CA19-9 and Carcinoembryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer.
Ma W; Li W; Wang J; Wu R; Liu C; Feng F; Jiang X
Med Sci Monit; 2020 Sep; 26():e925017. PubMed ID: 32950997
[TBL] [Abstract][Full Text] [Related]
5. Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma.
Wen Z; Si A; Yang J; Yang P; Yang X; Liu H; Yan X; Li W; Zhang B
HPB (Oxford); 2017 Nov; 19(11):951-956. PubMed ID: 28750922
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of platelet distribution width as novel biomarker in gall bladder cancer.
Siddeek RAT; Gupta A; Gupta S; Goyal B; Gupta AK; Agrawal S; Roshan R; Kumar U; Kumar N; Gupta M; Kishore S; Kant R
J Carcinog; 2020; 19():5. PubMed ID: 33033461
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancer.
Zhu XD; Zhang LX; Luo PQ; Zhu H; Wei ZJ; Xu AM
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12191-12201. PubMed ID: 37430160
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma.
Fang T; Wang H; Wang Y; Lin X; Cui Y; Wang Z
Dis Markers; 2019; 2019():6016931. PubMed ID: 30863466
[TBL] [Abstract][Full Text] [Related]
9. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of preoperative CA19-9 levels in evaluating resectability of gallbladder carcinoma.
Liu F; Wang JK; Ma WJ; Yang Q; Hu HJ; Li FY
ANZ J Surg; 2019 Mar; 89(3):E76-E80. PubMed ID: 30306702
[TBL] [Abstract][Full Text] [Related]
11. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.
Ahmadi H; Djaladat H; Cai J; Miranda G; Daneshmand S
Urol Oncol; 2014 Jul; 32(5):648-56. PubMed ID: 24680660
[TBL] [Abstract][Full Text] [Related]
12. Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer.
Sinha SR; Prakash P; Singh RK; Sinha DK
World J Gastrointest Surg; 2022 Nov; 14(11):1272-1284. PubMed ID: 36504513
[TBL] [Abstract][Full Text] [Related]
13. Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy.
Lee JW; Kim YT; Lee SH; Son JH; Kang JW; Ryu JK; Jang DK; Paik WH; Lee BS
Gut Liver; 2018 Jan; 12(1):102-110. PubMed ID: 29069888
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Zhang Y; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
16. Limits of serum carcinoembryonic antigen and carbohydrate antigen 19-9 as the diagnosis of gallbladder cancer.
Kang JS; Hong SY; Han Y; Sohn HJ; Lee M; Kang YH; Kim HS; Kim H; Kwon W; Jang JY
Ann Surg Treat Res; 2021 Nov; 101(5):266-273. PubMed ID: 34796142
[TBL] [Abstract][Full Text] [Related]
17. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
Kim YC; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Shin JH
J Gastroenterol Hepatol; 2009 Dec; 24(12):1869-75. PubMed ID: 19686409
[TBL] [Abstract][Full Text] [Related]
18. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer.
Ishigami S; Natsugoe S; Hokita S; Che X; Tokuda K; Nakajo A; Iwashige H; Tokushige M; Watanabe T; Takao S; Aikou T
J Clin Gastroenterol; 2001 Jan; 32(1):41-4. PubMed ID: 11154168
[TBL] [Abstract][Full Text] [Related]
19. p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis.
Agrawal V; Goel A; Krishnani N; Pandey R; Agrawal S; Kapoor VK
J Postgrad Med; 2010; 56(4):262-6. PubMed ID: 20935395
[TBL] [Abstract][Full Text] [Related]
20. Postoperative carcinoembryonic antigen as a complementary tumor marker of carbohydrate antigen 19-9 in pancreatic ductal adenocarcinoma.
Kim J; Lee YS; Hwang IK; Kang BK; Cho JY; Yoon YS; Han HS; Hwang JH
J Korean Med Sci; 2015 Mar; 30(3):259-63. PubMed ID: 25729247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
